IMGN News and Press, ImmunoGen Inc. From 05/15/20

Next Generation Anti-FRα ADC Demonstrates Potent Anti-Tumor Activity in Ovarian Cancer Models and Other FRα-positive Tumor Types in Preclinical Studies ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment ...

Combination Demonstrates Promising Anti-Tumor Activity and Favorable Tolerability, with a Confirmed Overall Response Rate of >60% in Patients with High FRα Expression Results to be Presented in an Oral Session at ASCO 2020 Virtual Scientific Program ImmunoGen, Inc. (Na...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Mark Enyedy, President and CEO, and Anna Berkenblit, Chief Medical Officer, will participate in a fireside chat at the upcoming RBC Capital Ma...

Shares of ImmunoGen (NASDAQ: IMGN) closed Monday trading up 15.7%. The drugmaker reported first-quarter results on Friday that missed analysts' expectations, which sent shares into a slump. However, investors shrugged those results off Monday, and apparently focused instead on the potential ...

ImmunoGen Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on April 30, 2020 the compensation committee of the Company’s Board of Directors granted non-qualified stock option awards to purchase an...

Image source: The Motley Fool. Immunogen Inc   (NASDAQ: IMGN) Q1 2020 Earnings Call May 1, 2020 , 8:00 a.m. ET Operator Continue reading

ImmunoGen, Inc. (IMGN) Q1 2020 Earnings Conference Call May 01, 2020, 08:00 ET Company Participants Courtney O’Konek - Senior Director, Corporate Communications & IR Mark Enyedy - President, CEO & Director Anna Berkenblit - SVP & Chief Medical Officer Confer...

ImmunoGen ( IMGN ) Q1 results : More news on: ImmunoGen, Inc., Healthcare stocks news, Earnings news and commentary, , Stocks on the move, Read more ...

ImmunoGen (NASDAQ: IMGN ): Q1 GAAP EPS of -$0.17 misses by $0.02 . More news on: ImmunoGen, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...